505 related articles for article (PubMed ID: 22885698)
1. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling.
Dühren-von Minden M; Übelhart R; Schneider D; Wossning T; Bach MP; Buchner M; Hofmann D; Surova E; Follo M; Köhler F; Wardemann H; Zirlik K; Veelken H; Jumaa H
Nature; 2012 Sep; 489(7415):309-12. PubMed ID: 22885698
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemia: a tale of one or two signals?
Chiorazzi N; Efremov DG
Cell Res; 2013 Feb; 23(2):182-5. PubMed ID: 23147791
[TBL] [Abstract][Full Text] [Related]
3. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
4. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.
Tobin G; Thunberg U; Karlsson K; Murray F; Laurell A; Willander K; Enblad G; Merup M; Vilpo J; Juliusson G; Sundström C; Söderberg O; Roos G; Rosenquist R
Blood; 2004 Nov; 104(9):2879-85. PubMed ID: 15217826
[TBL] [Abstract][Full Text] [Related]
5. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.
Binder M; Léchenne B; Ummanni R; Scharf C; Balabanov S; Trusch M; Schlüter H; Braren I; Spillner E; Trepel M
PLoS One; 2010 Dec; 5(12):e15992. PubMed ID: 21209908
[TBL] [Abstract][Full Text] [Related]
6. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.
Ghiotto F; Fais F; Valetto A; Albesiano E; Hashimoto S; Dono M; Ikematsu H; Allen SL; Kolitz J; Rai KR; Nardini M; Tramontano A; Ferrarini M; Chiorazzi N
J Clin Invest; 2004 Apr; 113(7):1008-16. PubMed ID: 15057307
[TBL] [Abstract][Full Text] [Related]
7. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
Chiorazzi N; Hatzi K; Albesiano E
Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
[TBL] [Abstract][Full Text] [Related]
8. Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens.
Jiménez de Oya N; De Giovanni M; Fioravanti J; Übelhart R; Di Lucia P; Fiocchi A; Iacovelli S; Efremov DG; Caligaris-Cappio F; Jumaa H; Ghia P; Guidotti LG; Iannacone M
EMBO Mol Med; 2017 Nov; 9(11):1482-1490. PubMed ID: 28899929
[TBL] [Abstract][Full Text] [Related]
9. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells.
Zwick C; Fadle N; Regitz E; Kemele M; Stilgenbauer S; Bühler A; Pfreundschuh M; Preuss KD
Blood; 2013 Jun; 121(23):4708-17. PubMed ID: 23580660
[TBL] [Abstract][Full Text] [Related]
10. Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL.
Iacovelli S; Hug E; Bennardo S; Duehren-von Minden M; Gobessi S; Rinaldi A; Suljagic M; Bilbao D; Bolasco G; Eckl-Dorna J; Niederberger V; Autore F; Sica S; Laurenti L; Wang H; Cornall RJ; Clarke SH; Croce CM; Bertoni F; Jumaa H; Efremov DG
Blood; 2015 Mar; 125(10):1578-88. PubMed ID: 25564405
[TBL] [Abstract][Full Text] [Related]
11. The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia.
Ten Hacken E; Gounari M; Ghia P; Burger JA
Leukemia; 2019 Feb; 33(2):287-298. PubMed ID: 30555163
[TBL] [Abstract][Full Text] [Related]
12.
Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
[TBL] [Abstract][Full Text] [Related]
13. B cell receptor signaling in chronic lymphocytic leukemia.
Burger JA; Chiorazzi N
Trends Immunol; 2013 Dec; 34(12):592-601. PubMed ID: 23928062
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?
García-Muñoz R; Llorente L
Immunology; 2014 Aug; 142(4):536-50. PubMed ID: 24645778
[TBL] [Abstract][Full Text] [Related]
15. Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia.
Muggen AF; Pillai SY; Kil LP; van Zelm MC; van Dongen JJ; Hendriks RW; Langerak AW
Leukemia; 2015 Feb; 29(2):321-8. PubMed ID: 24917358
[TBL] [Abstract][Full Text] [Related]
16. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.
Maura F; Cutrona G; Fabris S; Colombo M; Tuana G; Agnelli L; Matis S; Lionetti M; Gentile M; Recchia AG; Di Raimondo F; Musolino C; Ilariucci F; Di Renzo N; Pesce E; Molica S; Federico M; Cortelezzi A; Morabito F; Ferrarini M; Neri A
PLoS One; 2011; 6(8):e24313. PubMed ID: 21897877
[TBL] [Abstract][Full Text] [Related]
17. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
[TBL] [Abstract][Full Text] [Related]
18. Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia.
Rovida A; Maccalli C; Scarfò L; Dellabona P; Stamatopoulos K; Ghia P
Clin Cancer Res; 2021 Feb; 27(3):729-739. PubMed ID: 33051305
[TBL] [Abstract][Full Text] [Related]
19. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
[TBL] [Abstract][Full Text] [Related]
20. B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.
Binder M; Müller F; Jackst A; Léchenne B; Pantic M; Bacher U; Zu Eulenburg C; Veelken H; Mertelsmann R; Pasqualini R; Arap W; Trepel M
Cancer; 2011 May; 117(9):1891-900. PubMed ID: 21509766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
